A hospital epidemic of vancomycin-resistant Enterococcus: Risk factors and control

Infection Control and Hospital Epidemiology

Volumn 22, Issue 3, 2001, Pages 140-147

  Byers, Karin E ^a   Anglim, Anne M ^a   Anneski, Cynthia J ^a   Germanson, Teresa P ^a   Gold, Howard S ^b   Durbin, Lisa J ^a   Simonton, Barbara M ^a   Farr, Barry M ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CASE CONTROL STUDY; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0035087664     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501880     Document Type: Article

References (74)

1. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993
2. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci
3. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality
4. Vancomycin-resistant Enterococcus faecium (VRE) bacteremia in severely neutropenic patients
5. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?
6. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium
7. Multicenter surveillance for nosocomial enterococcal bacteremia: A comparison of vancomycin-sensitive vs vancomycin-resistant cases
8. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus
9. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC)
10. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System
11. Nosocomial vancomycin resistant enterococci (VRE) in the United States, 1989-1995: The first 1,000 isolates
12. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
13. Vancomycin-resistant Enterococcus faecium in hospitalized children
14. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
15. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit
16. A hospital outbreak of vancomycin-resistant Enterococcus faecium (VRE) controlled with intensive surveillance culturing and gown and glove isolation
17. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers
18. Control of endemic glycopeptide-resistant enterococci
19. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center
20. A comparison of the effect of universal use of gloves and gown with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit
21. CDC definitions for nosocomial infections
22. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections
23. Hospital acquired infection, I: Surveillance in a university hospital
24. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium
25. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium
26. Frequency of community acquired MRSA at a university hospital
27. Rapid detection of vancomycin-resistant enterococci
28. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristinquinupristin
29. Interpreting chromosomal DNA restriction patterns produced by pulsed-field electrophoresis: Criteria for bacterial strain typing
30. The analysis of case-control studies
31. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis
32. Regression modeling strategies for improved prognostic prediction
33. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units
34. Hand-washing patterns in medical intensive-care units
35. Compliance with handwashing in a teaching hospital. Infection Control Program
36. Colonization with vancomycin-resistant Enterococcus faecium: Comparison of a long-term-care unit with an acute-care hospital
37. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients
38. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces
39. Nosocomial gastrointestinal tract infections
40. Control of nosocomial gastrointestinal infections
41. High-level resistance to gentamicin in Streptococcus faecalis: Risk factors and evidence for exogenous acquisition of infection
42. High-level aminoglycoside-resistant enterococci: Colonization of nursing home and acute care hospital patients
43. Epidemic acquired immune deficiency syndrome: Epidemiologic evidence for a transmissible agent
44. Epidemiology of vancomycin-resistant enterococci (VRE) at Thomas Jefferson University Hospital (TJUH)
45. Vancomycin-resistant Enterococcus faecium in a VA Medical Center
46. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas
47. An outbreak of vancomycin-resistant enterococci (VRE) in a suburban VA medical center
48. Fecal carriage of vancomycin-resistant enterococci (VRE) in nursing home (NH) and hospitalized patients
49. Risk factors for acquisition of vancomycin-resistant Enterococcus
50. Third generation cephalosporins are an important risk factor for acquisition of vancomycin resistant enterococci
51. Vancomycin-resistant Enterococcus faecium (VREF) - Outbreak comparison of analytic methods
52. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin
53. Are vancomycin resistant enterococci (VRE) normal inhabitants of the G.I. tract of hospitalized patients?
54. Recycling of hospital-acquired colonization with vancomycin resistant enterococci via nursing home residents
55. Prospective study of the epidemiology of vancomycin-resistant enterococcus (VRE) colonization among ICU patients
56. A hospital based stool culture survey to detect vancomycin resistant enterococcus (VRE) - Utility and application
57. Prior therapy with oral vancomycin increases the risk of rectal colonization with vancomycin-resistant Enterococcus faecium (VRE)
58. When is it safe to take patients colonized with vancomycin-resistant Enterococcus faecium (VREF) off isolation?
59. Epidemiologic correlation of the incidences of vancomycin-resistant Enterococcus faecium (VREF) infection and Clostridium difficile colitis in a VA medical center
60. High rate of vancomycin resistant Enterococcus (VRE) in a large teaching hospital; a community based problem?
61. Vancomycin-resistant enterococcal (VRE) blood isolates in New Jersey (NJ) hospitals: An 18-month statewide study
62. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
63. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
64. Risk factors for infection with vancomycin-resistant Enterococcus faecium at a VA medical center
65. Investigation of an outbreak of vancomycin-resistant Enterococcus faecium by random amplified polymorphic DNA (RAPD) assay
66. Epidemiology
67. Management of vancomycin-resistant enterococci in U.S. hospitals
68. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci
69. The natural history of carriage of VRE using PCR detection of Van A, Van B, and Van C directly from stool samples/rectal swabs: What we don't know can't hurt us, can it?
70. Natural history of colonization with vancomycin-resistant Enterococcus faecium
71. Duration of colonization with VRE
72. Vancomycin resistant enterococci